- ►annals.org [PDF] JM Kremer - Annals of internal medicine, 2001 - Am Coll Physicians Because of radiographic evidence of progressive bone loss and the inability to
eliminate synovial proliferation with methotrexate, it became apparent that
therapy for rheumatoid arthritis needed further advancement. Methotrexate ... Cited by 156 - Related articles - BL Direct - All 9 versions
- ►oxfordjournals.org P Emery, JY Reginster, T Appelboom, FC … - Rheumatology, 2001 - Br Soc Rheumatology Severe adult rheumatoid arthritis is a cause of progressive disability and
increased mortality across Europe. A cure for the disease remains elusive, but
control of symptoms and maintenance of individual independence is possible. ... Cited by 54 - Related articles - BL Direct - All 5 versions
F Wolfe, JJ Cush, JR O'Dell, A Kavanaugh, … - J Rheumatol, 2001 - arthritis-research.org The treatment of rheumatoid arthritis (RA) has changed dramatically during the
last decade. The increasing use of methotrexate (MTX) (1-3), combination
therapies (4-6) and anti-TNF agents (7-12) have made obsolete the treatment ... Cited by 58 - Related articles - View as HTML - BL Direct - All 12 versions
ME Weinblatt, JM Kremer, JS Coblyn, AL … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 221 - Related articles - BL Direct - All 3 versions
- ►annals.org [PDF] JM Kremer, MC Genovese, GW Cannon, JR … - Annals of internal medicine, 2002 - Am Coll Physicians Joel M. Kremer, MD; Mark C. Genovese, MD; Grant W. Cannon, MD; Jacques R.
Caldwell, MD; John J. Cush, MD; Daniel E. Furst, MD; Michael E. Luggen, MD; Ed
Keystone, MD; Michael H. Weisman, MD; William M. Bensen, MD; Jeffrey L. ... Cited by 206 - Related articles - BL Direct - All 4 versions
JM Kremer - Arthritis and rheumatism, 1997 - cat.inist.fr Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid
arthritis taking methotrexate: followup after a mean of 13. 3 years. ... Cited by 69 - Related articles - BL Direct - All 2 versions
서창희 - HANYANG MEDICAL REVIEWS, 2005 - hanyang.ac.kr Abstract Rheumatoid arthritis (RA) is a chronic progressive disease, affecting
an estimated 1% of the population worldwide. Although the optimal care of RA
patients requires various modalities, pharmacotherapy remains the ... Related articles - View as HTML - All 3 versions
ME Weinblatt, AL Maier, PA Fraser, JS Coblyn - Journal of rheumatology, 1998 - cat.inist.fr Objective. To conclude observations of efficacy of longterm methotrexate(MTX)
treatment of rheumatoid arthritis(RA). Methods. Twenty-six patients with RA
entered a prospective study of MTX in 1983. The study was completed after ... Cited by 88 - Related articles - BL Direct - All 2 versions
P Ranganathan, R Culverhouse, S Marsh, R … - pgs, 2004 - Future Medicine Methotrexate (MTX) is a commonly used disease-modifying antirheumatic drug in
rheumatoid arthritis (RA). Polymorphisms occur in several genes encoding key
enzymes in the folic acid pathway, which is influenced by MTX, but have not ... Cited by 26 - Related articles - All 4 versions
